Find your path to Markus
159 people in our graph share verified history with Markus — schools, employers, funds. One of them is your warm intro.
Rami HannoushunlockedMarkus: together at Light Horse Therapeutics (2024–2026)
×11Markus: together at Stanford University School of Medicine
Executive at Cyteir Therapeutics
Intro paths
→
In turn, Markus can intro founders to Cyteir Therapeutics's investors below.
Cyteir Therapeutics's investors · 9
Ally Bridge GroupNew York · since 2021Droia VenturesLeuven · $540K checks · since 2021Janus Henderson InvestorsLondon · since 2021Lightstone VenturesPortola Valley · since 2021Novo HoldingsCopenhagen · $1.1M – $54M checks · since 2021Osage University PartnersBala CynwydOUP (Osage University Partners)Bala Cynwyd · $1M – $20M checksRA CapitalBoston · since 2021VenrockPalo Alto · $500K – $10M checks · since 2021
Experience
- Light Horse TherapeuticsChief Executive Officercurrent2024 — presentSan Diego, CA
- Cyteir TherapeuticsPresident and CEO2018 — 2024Cambridge, MA
- CelgeneSenior Vice President and Chief Medical Officer, Celgene Cellular Therapeutics2017Warren, NJ
- CelgeneSenior Vice President, Global Head, Hematology & Oncology Medical Affairs2014 — 2017
- CelgeneCorp VP, Global Head, Hematology & Oncology Medical Affairs2013 — 2014
- CelgeneVP, Clinical Development2008 — 2012
- CelgeneVP, Business Development2010San Francisco Bay Area
- PharmionVP, Clinical Development2007 — 2008San Francisco Bay Area
- PharmacyclicsDir to Sr VP, Oncology Clinical Development1996 — 2007Sunnyvale
Skills & more
OncologyHematologyClinical TrialsBiotechnologyPharmaceutical IndustryClinical DevelopmentMedical AffairsCancer ResearchData AnalysisBusiness DevelopmentRegulatory AffairsDrug Safety
+12 more
StatisticsTranslational MedicineBiostatisticsClinical Data ManagementCommercializationTranslational ResearchINDCardiologyImmunologyCancerClinical OperationsMarket AccessFrom Markus's professional profile.
Frequently asked questions
- Who is Markus Renschler?
- Director at Cyteir Therapeutics
- Where does Markus Renschler work?
- Markus Renschler is Executive at Cyteir Therapeutics.
- Where did Markus Renschler go to school?
- Markus Renschler studied at Stanford University School of Medicine (Doctor of Medicine (M.D.)); Princeton University (Bachelor’s Degree, Public and International Affairs).
Same school
Also attended Stanford University School of Medicine158
Jeffrey FinerVenture Partner at Third Rock VenturesRebecca MancusiInvestor at Third Rock VenturesAlex MorganInvestor at Khosla VenturesLauren PopovAssociate at Westlake Village BioPartnersClare OzawaManaging Director at Versant VenturesLily SarafanInvestor at Streamlined Ventures
+ 152 more
Also attended Princeton University997
Fabrice GrindaCo-founder & Managing Partner at FJ LabsRyan SheaCo-founder of Blockstack (Stacks)Dario AmodeiCo-founder & CEO of AnthropicFei-Fei LiCo-founder & CEO of World Labs; Sequoia Professor of Computer Science at StanfordCat WuInvestor at Index VenturesAndrewAdvisor at Clear Ventures
+ 991 more
Shared employers
Also worked at Light Horse Therapeutics3
Also worked at Cyteir Therapeutics2
Also worked at Celgene41
Courtney WallaceInvestor at Third Rock VenturesJoyce BremerInvestor at True VenturesPatrick LoerchBio Advisor at Amplify PartnersGeorge GolumbeskiPartner at Droia VenturesMichael KramarzManaging Partner at Commodore CapitalLisa WisniewskiManaging Director at Global BioAccess Fund
+ 35 more
